Prolonged β2-agonist treatment enhances muscle-specific glucose uptake in individuals with overweight and obesity: a randomized placebo-controlled trial.
Van Lier PMG, van de Weijer T, Vanweert F, Brouwers K, Nijssen KMR, Schaart G, Moonen-Kornips E, van Beek SMM, Springer S, Wierts R, Joris PJ, Schrauwen-Hinderling VB, Phielix E, Bengtsson T, Schrauwen P, Hoeks J.
Van Lier PMG, et al. Among authors: joris pj.
Nat Commun. 2026 Apr 21;17(1):5483. doi: 10.1038/s41467-026-71897-9.
Nat Commun. 2026.
PMID: 42014715
Free PMC article.
Clinical Trial.